Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-24 @ 3:03 PM
NCT ID:
NCT02601859
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of Mild Cognitive Impairment (MCI).
Exclusion Criteria:
* Previous hypersensitivity to Lithium or other contraindication to Lithium carbonate Priadel (see most recent SmPC), Dementia Diabetes BMI \<18 or \>30 Rheumatoid Arthritis and Autoimmune Inflammatory disorders Currently taking NSAIDS Moderate renal failure (defined in BNF by gGFR \<60 mL/minute/1.73m2) or severe Renal failure (defined in BNF by eGFR \<29 mL/minute/1.73m2 Addison's disease, Brugada syndrome (or family history of Brugada syndrome), cardiac insufficiency, congestive cardiac failure, epilepsy, suicidality incapacity to consent currently prescribed lithium participation in another clinical trial of an Investigational Medicinal Product (IMP) in the last 28 days.
Uncontrolled serious concomitant physical illness
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
55 Years
Study:
NCT02601859
Study Brief:
Protocol Section:
NCT02601859